研究紹介(論文)

A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11

Hironaga Satake, Yu Sunakawa, Yuji Miyamoto, Masato Nakamura, Hiroshi Nakayama, Manabu Shiozawa, Akitaka Makiyama, Kazuma Kobayashi, Yutaro Kubota, Misuzu Mori, Masahito Kotaka, Akinori Takagane, Masahiro Gotoh,  Masahiro Takeuchi, Masashi Fujii, Wararu Ichikawa, Takashi Sekikawa

 Oncotarget, 2018, Vol. 9, (No. 27), pp: 18811-18820